[Skip to Content]

Upstate Active Clinical Trials

Study Title:

A Phase 2 Dose Ranging Study to Evaluate the Efficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE) With Inadequate Response to Standard of Care (SOC) Therapy. 20170588

Upstate Institutional Review Board (IRB) Number:

1607275

Study/Protocol ID:

20170588

Study Phase:

2

Patient Age Group:

Adults

Principal Investigator:

Andras Perl, MD, PhD

Who can I contact for more information?

Name: Joanne M Chilton, CCRP
Phone: 315-464-8240
Email: chiltonj@upstate.edu

Return to Previous Page || Search Again

Top